ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $46,562,000 | +37.1% | 813,600 | +16.2% | 1.24% | +114.9% |
| Q2 2018 | $33,964,000 | +24.1% | 700,000 | 0.0% | 0.58% | +19.9% |
| Q1 2018 | $27,370,000 | -7.9% | 700,000 | 0.0% | 0.48% | -4.2% |
| Q4 2017 | $29,708,000 | +13.7% | 700,000 | 0.0% | 0.50% | +16.7% |
| Q3 2017 | $26,124,000 | +22.8% | 700,000 | 0.0% | 0.43% | +31.7% |
| Q2 2017 | $21,273,000 | +14.8% | 700,000 | 0.0% | 0.33% | -8.6% |
| Q1 2017 | $18,529,000 | +45.2% | 700,000 | +40.0% | 0.36% | +26.0% |
| Q4 2016 | $12,760,000 | +17.5% | 500,000 | +66.7% | 0.28% | +28.4% |
| Q3 2016 | $10,857,000 | – | 300,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |